• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The glass half-full: How optimism can bias prognosis in serious illness

Bioengineer by Bioengineer
April 25, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Most people think of optimism as a good thing – a positive outlook in challenging circumstances. But in reality, it’s a psychological state that can be “contagious” in a bad way. A new study, published in the journal Psycho-Oncology, details how a seriously ill patient’s optimism can impact a clinician’s survival prognosis in palliative care conversations.

Senior author Robert Gramling, M.D., D.Sc., associate professor of family medicine and the Miller Chair in Palliative Medicine at the University of Vermont’s Larner College of Medicine, and colleagues at Purdue University, the University of Rochester and University of California San Francisco, state that clinicians have a duty to estimate prognosis as accurately as possible. If survival is overestimated, Gramling and his coauthors write, “these errors in judgment can prevent patients from making timely decisions about their end-of-life care.”

For their study, the researchers enrolled 189 hospital patients with advanced cancer undergoing palliative care consultations at two geographically distant sites. A total of 41 palliative care clinicians participated in the recorded consultations.

Using established measurement tools, the group calculated the frequency and distribution of such variables as “clinician overestimation of survival time,” “patient (trait) dispositional optimism,” and “patient prognostic (state) optimism” and tracked patient survival and date of death and correlated it to clinical judgement.

The group’s findings showed a generally high level of both dispositional and prognostic optimism just before palliative care consultation, as well as a correlation between higher levels of patient optimism and clinicians’ greater likelihood of overestimating survival, even after adjusting for clinical markers of survival time.

“Our study suggests that patient-level optimism might exert an unforeseen influence over palliative care clinicians’ prognostic judgments,” write the study authors, who add that “If so, then raising clinician awareness about these effects and including de-biasing steps in prognostication skills training may lead to more accurate estimates.”

Data analyses for the study took place at the Vermont Conversation Lab at the University of Vermont, where Gramling and his colleagues both conduct research and develop training sessions through their TalkVermont program to help clinicians gain conversational proficiency.

###

This study was funded by a Research Scholar Grant from the American Cancer Society.

Media Contact
Jennifer Nachbur
[email protected]

Tags: BehaviorcancerDeath/DyingDecision-making/Problem SolvingMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.